手术切除与消融治疗浅表子宫内膜异位症相关疼痛:一项随机对照试验
该随机对照试验在单中心学术三级医院纳入73例轻度子宫内膜异位症患者,术中随机分配至切除组(37例)或消融组(36例),随访12个月。消融组痛经在6个月和12个月改善,性交痛在6个月改善但12个月未维持;切除组各VAS评分无显著变化;仅性交痛在6个月时组间差异显著。结论认为两种方法对浅表子宫内膜异位症相关疼痛疗效相似。
要点
- 消融组痛经VAS在6个月和12个月均较基线改善,切除组各时间点无显著变化。
- 消融组性交痛6个月改善但12个月未维持,组间仅6个月性交痛变化差异显著。
- 两种方法对浅表子宫内膜异位症相关疼痛疗效相似,消融组个体变化更显著。
核心结论
- 消融治疗较术前数据改善6个月和12个月痛经及6个月性交痛,但仅性交痛在消融与切除间差异显著。
- 切除与消融对浅表子宫内膜异位症相关疼痛疗效相似,消融显示更显著的个体变化。
- 作者认为管理子宫内膜异位症时,就手术干预预期进行仔细的患者咨询至关重要。
研究设计与样本
- 随机临床试验,随访12个月(加拿大工作组分类I)。
- 单中心学术三级医院,纳入因轻度子宫内膜异位症行腹腔镜的女性。
- 2013年12月至2014年10月术中随机73例至切除组(n=37)或消融组(n=36),在机器人辅助腹腔镜下行浅表子宫内膜异位症切除或消融。
主要发现
- 消融组性交痛VAS 6个月平均变化-14.07(95%CI -25.93至-2.21;p=.02),12个月未维持改善。
- 消融组痛经VAS 6个月平均变化-26.99(95%CI -41.48至-12.50;p<.001),12个月平均变化-24.15(95%CI 39.62至-8.68;p=.003)。
- 切除组6个月和12个月VAS评分无显著变化。
- 消融与切除比较,仅6个月性交痛变化差异显著(平均变化-22.96;95%CI -39.06至-6.86;p=.01)。
关键数值与推荐
- 主要结局为基线和6、12个月月经痛、非月经痛、性交痛和排便痛的视觉模拟量表(VAS)评分。
- 次要结局包括基线和6、12个月的健康调查简表、盆腔器官脱垂/尿失禁性功能问卷和国际盆腔疼痛评估调查结果。
临床怎么用
- 作者认为就手术干预的预期进行仔细的患者咨询在子宫内膜异位症管理中至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To compare surgical excision and ablation of endometriosis for treatment of chronic pelvic pain. DESIGN: Randomized clinical trial with 12-month follow-up (Canadian Task Force classification I). SETTING: Single academic tertiary care hospital. PATIENTS: Women with minimal to mild endometriosis undergoing laparoscopy. INTERVENTIONS: Excision or ablation of superficial endometriosis at the time of robot-assisted laparoscopy. MEASUREMENTS AND MAIN RESULTS: Primary outcome was visual analog scale (VAS) scoring at baseline and 6 and 12 months for menstrual pain, nonmenstrual pain, dyspareunia, and dyschezia. Secondary outcomes included survey results at baseline and 6 and 12 months from the Short Form Health Survey, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire, and the International Pelvic Pain Assessment. From December 2013 to October 2014, 73 patients were randomized intraoperatively to excision (n = 37) or ablation (n = 36) of endometriosis. Patients were followed at 6 and 12 months to evaluate the above outcomes. After ablation of endometriosis, dyspareunia (VAS scores) improved at 6 months (mean change [MC], -14.07; 95% confidence interval [CI], -25.93 to -2.21; p = .02), but improvement was not maintained at 12 months. Dysmenorrhea improved at 6 months (MC, -26.99; 95% CI, -41.48 to -12.50; p < .001) and 12 months (MC, -24.15; 95% CI, 39.62 to -8.68; p = .003) with ablation. No significant changes were seen in VAS scores after excision at 6 or 12 months. When comparing ablation and excision, the only significant difference was a change in dyspareunia at 6 months (MC, -22.96; 95% CI, -39.06 to -6.86; p = .01). CONCLUSION: Treatment with ablation improved dysmenorrhea at 6 and 12 months and improved dyspareunia at 6 months as compared with preoperative data. However, only dyspareunia demonstrated a significant difference between ablation and excision. Excision and ablation showed similar effectiveness for the treatment of pain associated with superficial endometriosis, with ablation showing more significant individual changes. Careful patient counseling regarding expectations of surgical intervention is vital in the management of endometriosis.
引用
- Riley KA, Benton AS, Deimling TA, et al. Surgical Excision Versus Ablation for Superficial Endometriosis-Associated Pain: A Randomized Controlled Trial. J Minim Invasive Gynecol. 2018. PMID: 29609032. doi:10.1016/j.jmig.2018.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。